Minimal risk in research is a regulatory standard used to classify studies where the chance and severity of harm to participants are no greater than what a person would encounter in everyday life or during a routine medical checkup. This threshold, defined in federal regulations at 45 CFR 46.102, is the single most important dividing line in human subjects research. It determines how much oversight a study receives, what protections participants need, and how quickly a project can get approved.
The Federal Definition
The official definition reads: “Minimal risk means that the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests.” Both the Department of Health and Human Services (HHS) and the FDA use this identical language in their respective regulations.
Two components matter here. “Probability” refers to how likely it is that something harmful will happen. “Magnitude” refers to how serious that harm would be if it did happen. A study qualifies as minimal risk only when both components fall within the everyday-life benchmark. A procedure that is almost certainly harmless but could, in rare cases, cause serious injury may not qualify. Neither would something that reliably causes moderate discomfort well beyond what you’d experience in a normal day.
The “Whose Daily Life?” Problem
The definition sounds straightforward until you ask a basic question: whose daily life are we comparing to? A firefighter’s daily risk profile looks nothing like an office worker’s. A prisoner’s daily environment involves different hazards than a college student’s. Early federal guidance muddied this by suggesting minimal risk should be measured against “the daily lives of the subjects of the research,” which would have allowed riskier studies on people already living in dangerous conditions.
That approach has been widely rejected. A consensus developed across multiple federal advisory committees that tying the risk standard to a specific population creates an unjust distribution of research burdens. If prisoners face more danger every day, that shouldn’t mean researchers can subject them to greater risk. The current expert consensus, endorsed by the Secretary’s Advisory Committee on Human Research Protections, is that minimal risk should reflect “background risks that are familiar and part of the routine experience of life for the average person in the general population.” In practice, this means healthy people living in safe environments are the benchmark, regardless of who actually enrolls in the study.
For research involving prisoners specifically, federal regulations make this explicit. Subpart C of the Common Rule defines minimal risk as “the probability and magnitude of physical or psychological harm that is normally encountered in the daily lives, or in the routine medical, dental, or psychological examination of healthy persons.” That “healthy persons” standard is what many experts believe should apply across all populations.
What Qualifies as Minimal Risk
The easiest way to understand minimal risk is through the types of research that typically fall under it. Federal guidelines list several categories of procedures that generally qualify:
- Surveys, interviews, and focus groups that ask about opinions, behaviors, or experiences without probing deeply traumatic topics
- Blood draws by finger stick, heel stick, ear stick, or standard venipuncture in healthy adults, within specified volume limits
- Noninvasive biological specimen collection like saliva swabs, urine samples, or hair clippings
- Noninvasive clinical measurements routinely used in practice, such as weighing someone, taking blood pressure, or recording an EEG (but not procedures involving X-rays or microwaves)
- Audio, video, or digital recordings made for research purposes
- Analysis of existing records or specimens that were originally collected for non-research purposes, such as medical charts or stored tissue samples
- Research on approved drugs or devices when used within their normal parameters and no investigational drug application is required
These examples cover most of what happens in behavioral, social science, and low-intervention biomedical research. The common thread is that participants face risks comparable to things they’d encounter during a regular doctor’s visit or in the course of a normal week.
What Falls Outside Minimal Risk
Risk in research isn’t limited to physical harm. Psychological, social, economic, and legal risks all count. A survey asking about illegal drug use, for instance, could expose participants to legal consequences if their data were breached, pushing the study above minimal risk depending on how identifiable the responses are. Research that involves deception, asks about traumatic experiences, or could reveal stigmatized conditions may also exceed the threshold if the potential psychological distress goes beyond what someone would normally encounter.
On the biomedical side, any procedure involving more than a routine blood draw, any experimental drug or device, surgical interventions, radiation exposure, or prolonged physical discomfort will almost always exceed minimal risk. The key question is always whether the worst plausible outcome of participating is meaningfully worse than what the average healthy person faces in ordinary life.
Why the Classification Matters
The minimal risk designation has enormous practical consequences for how research is reviewed and conducted. Studies that meet the minimal risk threshold can go through expedited review, meaning a single experienced member of an Institutional Review Board (IRB) can approve the project rather than convening the full committee. This can shave weeks or months off the approval timeline. Some minimal risk studies involving publicly available data or anonymous surveys may even qualify for exemption from IRB review entirely.
Studies that exceed minimal risk require full board review, where a quorum of IRB members discusses the protocol, votes on approval, and often requests modifications to better protect participants. The informed consent process is typically more rigorous, and ongoing monitoring requirements are stricter.
Special Rules for Children
When research involves children, the minimal risk classification takes on added weight. Federal regulations under Subpart D create a tiered approval system based on risk level. An IRB can approve research involving children under Section 404 if it finds the risks are no greater than minimal. The same definition of minimal risk from the Common Rule applies, but the practical standard is calibrated to what healthy children encounter in daily life or routine pediatric exams, not what adults experience.
If a study involving children exceeds minimal risk, it faces additional requirements. The IRB must determine whether the added risk is justified by potential direct benefit to the child, or whether the knowledge to be gained is vital enough to justify a “minor increase over minimal risk.” All research with children requires both parental permission and, when appropriate, the child’s own agreement to participate (called assent). These layered protections exist because children cannot fully evaluate research risks for themselves.
How IRBs Make the Call
In practice, determining whether a study is minimal risk involves judgment, not a formula. IRB members review the specific procedures, the population being studied, the sensitivity of the data being collected, and the safeguards in place to protect participants. They weigh both components of the definition: how likely is harm, and how bad would it be?
This judgment call is one reason the same study can be classified differently by different IRBs. A questionnaire about workplace stress might be minimal risk at one institution and flagged for full review at another if the target population includes people in crisis situations. The lack of a precise, quantitative threshold is a well-known limitation of the current system, and it’s the source of ongoing debate among ethicists, researchers, and regulators. Still, the minimal risk standard remains the foundational concept in research ethics review, shaping how millions of studies involving human participants are evaluated each year.